The Effect of Hysterotomy Technique on the Rate of Large Defects in the Hysterotomy Scar

May 17, 2018 updated by: Region Skane
The Effect of Cesarean Operative Technique on the Occurrence of Large Hysterotomy Scar Defects.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Having a Caesarean leads to a scar in the uterus, which does not always heal properly. Defective healing can lead to serious complications in the next pregnancy and delivery. Different surgical techniques can be used for a Caesarean section.

The aim is to compare two surgical techniques (different ways of opening the uterus), to investigate whether one or the other technique leads to fewer defective scars in the uterus. Both these techniques are in use at the clinic. After the operation, patients are cared for in the normal way.

Six months after the Caesarean, patients are examined using vaginal ultrasound. Vaginal ultrasound allows to see if the scar after the Caesarean has healed well, or if there are defects in it.

Study Type

Interventional

Enrollment (Actual)

122

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Malmö, Sweden, Se 20502
        • Skåne University Hospital Malmö

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

inclusion criteria:

  • ≥ 18 years old
  • gestational age ≥ 37 gestational weeks
  • cervical dilatation ≥5 cm,
  • no previous uterine surgery other than cone biopsy, loop electrosurgical excision procedure, dilatation and curettage, or dilatation and evacuation, undergoing emergency caesarean section.

exclusion criteria:

• need of immediate caesarean section, defined as delivery of the baby within 20 minutes.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: high incision group
hysterotomy at cesarean performed 2 cm above plica vesicouterina
incision to open the uterus at cesarean.
ACTIVE_COMPARATOR: low incision group
hysterotomy at cesarean performed 2 cm below plica vesicouterina
incision to open the uterus at cesarean.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
large defect
Time Frame: 6 months
occurrence of large defects in uterine cesarean scar are detected by ultrasound and are assessed by the percentage of patients who have large defects in uterine cesarean scar
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
APGAR score
Time Frame: 1 and 5 minute after delivery
APGAR score measured at 1 and 5 minute after delivery. The five criteria are summarized using words chosen to form a backronym (Appearance, Pulse, Grimace, Activity, Respiration).The Apgar scale is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing up the five values thus obtained. The resulting Apgar score ranges from zero to 10.
1 and 5 minute after delivery
blood loss
Time Frame: 1 hour
estimated blood loss during surgery is measured in terms of mL
1 hour
difficulties at delivery of fetus
Time Frame: 1 hour
difficulties at delivery of fetus at caesarean are assessed by the percentage of patients when surgeons experience difficulties at delivery of fetus at caesarean
1 hour
postoperative infection
Time Frame: 8 weeks
postoperative infection after caesarean section is assessed by the percentage of patients who develop this complication
8 weeks
readmission to the hospital
Time Frame: 8 weeks
readmission to the hospital due to need of re-operation is assessed by the percentage of patients who have re-operation after caesarean
8 weeks
miscarriage
Time Frame: up to 8 years
occurrence of miscarriage in subsequent pregnancy is assessed by the percentage of patients who have miscarriages in subsequent pregnancy
up to 8 years
scar pregnancy
Time Frame: up to 8 years
occurrence of scar pregnancy in subsequent pregnancy is assessed by the percentage of patients who have scar pregnancy after the index caesarean
up to 8 years
placenta previa/accreta
Time Frame: up to 8 years
occurrence of placenta previa/accreta in subsequent pregnancy is assessed by the percentage of patients who have placenta previa/accreta in subsequent pregnancy
up to 8 years
uterina rupture/uterine dehiscence
Time Frame: up to 8 years
occurrence of uterine rupture/uterine dehiscence in subsequent labour is assessed by the percentage of patients who have uterine rupture/uterine dehiscence in subsequent labour
up to 8 years
vaginal delivery after caesarean
Time Frame: up to 8 years
success rate of vaginal delivery after caesarean is assessed by the percentage of patients who delivered vaginally after the index caesarean
up to 8 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Olga Vikhareva, MD, PhD, Skane University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 1, 2009

Primary Completion (ACTUAL)

December 1, 2016

Study Completion (ACTUAL)

October 31, 2017

Study Registration Dates

First Submitted

March 19, 2010

First Submitted That Met QC Criteria

March 22, 2010

First Posted (ESTIMATE)

March 23, 2010

Study Record Updates

Last Update Posted (ACTUAL)

May 22, 2018

Last Update Submitted That Met QC Criteria

May 17, 2018

Last Verified

May 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

  • 2-valentin

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe